VAERS reports by lot

GSK Varicella/Shingles lot 7TA92: VAERS reports

24 VAERS reports list lot 7TA92 as a GSK Varicella/Shingles vaccine, received between 2023-10-19 and 2024-10-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2324%
General / Systemic (non-local)2122%
Cardiac / Cardiovascular1718%
Neurological910%
Musculoskeletal910%
Thrombotic / Hematological77%
Dermatological (non-injection-site)55%
Allergic / Anaphylactic11%
Respiratory11%
Gastrointestinal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Indiana4
North Carolina4
Ohio2
California2
Texas2
Maryland1
New York1
Vermont1
Missouri1
Kentucky1
Pennsylvania1
Florida1

Reports by month received

2023-102
2023-114
2023-125
2024-012
2024-041
2024-051
2024-068
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.